Transcatheter aortic valve replacement (TAVR) is a safe and feasible alternative to surgery
in patients with symptomatic severe aortic stenosis regardless of the surgical risk …

Transcatheter aortic valve replacement (TAVR) has become a well-accepted option for
treating patients with aortic stenosis at intermediate to high or prohibitive surgical risk. TAVR …

Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …

The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

Aims The clinical impact of new-onset persistent left bundle branch block (NOP-LBBB) and
permanent pacemaker implantation (PPI) on transcatheter aortic valve replacement (TAVR) …

Objectives: The purpose of this study was to identify predictors and clinical implications of
permanent pacemaker (PPM) implantation after transcatheter aortic valve replacement …

Background—Available data on the clinical impact of new-onset left bundle branch block
(LBBB) and permanent pacemaker implantation (PPI) after transcatheter aortic valve …

Background: Little evidence exists of the burden and predictors of cardiac death after
transcatheter aortic valve replacement (TAVR). Objectives: The purpose of this study was to …

Objectives: The authors sought to determine: 1) the global arrhythmic burden; 2) the rate of
arrhythmias leading to a treatment change; and 3) the incidence of high-degree …

Background: Left ventricular ejection fraction (LVEF) is reduced in a subset of patients with
severe aortic stenosis (AS). Objectives: The authors sought to determine the temporal …